Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
62.3M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
+13.1M
-
Total reported value, excl. options
-
$220M
-
Value change
-
+$220M
-
Number of buys
-
32
-
Price
-
$16.98
Significant Holders of Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share (AURA) as of Q4 2021
32 filings reported holding AURA - Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q4 2021.
Aura Biosciences, Inc. - Common Stock, $0.00001 par value per share (AURA) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
of 62.3M outstanding shares and own 21.01% of the company stock.
Largest 10 shareholders include Matrix Capital Management Company, LP (4.11M shares), Medicxi Ventures Management (Jersey) Ltd (3.04M shares), CITADEL ADVISORS LLC (2.32M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.26M shares), Rock Springs Capital Management LP (1.01M shares), FMR LLC (471K shares), BlackRock Inc. (239K shares), VANGUARD GROUP INC (226K shares), GEODE CAPITAL MANAGEMENT, LLC (102K shares), and Nantahala Capital Management, LLC (99.1K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.